Objective Adolescent depression is a highly prevalent and disabling mental disorder with unclear pathophysiology and unfavorable treatment outcomes. Recent efforts have been focusing on searching for biomarkers as specific indicators of adolescent depression. We performed a systematic literature review and meta-analysis, specifically including studies with healthy control groups as an inclusion criterion. This approach helps to avoid confounding factors and provides more accurate results regarding the inflammatory and immune biomarkers associated with adolescent depression.Methods Three electronic databases were searched for studies comparing the means and changes in the biomarkers between depressed adolescent patients and healthy controls published in English until February 2024. Two authors independently performed the screening, quality assessment, and data extraction of the studies. A meta-analysis was conducted on outcomes reported by two or more studies using a random-effects model and presented Forrest plots and test statistics (I2) for heterogeneity analysis.Results Nine studies were included in the review, including seven case-control studies and two cross-sectional studies. These studies included 24 target biomarkers, 13 of which were quantified in 2 or more studies. Compared to the healthy controls, the depressed adolescents had significantly higher values in ten indicators. Additionally, the depressed adolescents had lower procalcitonin levels than the healthy controls. The two groups showed no significant differences in the remaining 13 biomarkers.Conclusion Our findings offer fresh insights into the pathophysiology of inflammatory and immune aspects of adolescent depression and provide helpful guidance in developing targeted and effective intervention and prevention strategies to address adolescent depression.
Background: Obesity and depressive disorders are significant public health concerns, and their association is well-documented. This study investigates the role of inflammatory markers, specifically C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), in mediating the relationship between obesity and depressive symptoms. Methods: We utilized data from 37,538 adults from the National Health and Nutrition Examination Survey (NHANES), covering the period from 2005 to March, 2020, pre-pandemic. Depressive symptoms were measured using the Patient Health Questionnaire-9 (PHQ-9), while inflammatory markers were assessed via NLR and CRP levels. Results: Results indicated a positive correlation between obesity, NLR, and CRP levels, and depressive symptoms. Notably, CRP exhibited a significant mediating effect in the obesity and depressive symptoms link, whereas NLR did not. (NLR: 0.0926%, p = 0.740; CRP: 32%, p < 0.001). Furthermore, the mediating effect of CRP in the male group was significantly higher than in the female group (Men: 57%, p < 0.001; Women: 16%, p = 0.046). Conclusion: These findings provide new insights into the mechanisms linking obesity and depressive symptoms, especially in men, and may guide future therapeutic strategies.
Background: Dilated cardiomyopathy (DCM) represents the most prevalent form of pediatric cardiomyopathy. However, the characteristics and etiology of this condition across different pediatric age groups remain incompletely elucidated. Methods and results: Data from 88 pediatric patients aged <14 years diagnosed with primary DCM between January 2021 and December 2023 were retrospectively retrieved from the institutional database and analyzed. Patients were stratified into two groups using a 3-year age cutoff. Clinical characteristics, echocardiographic parameters, and biomarkers were documented for each patient to facilitate subsequent analysis. Of these patients, 11 underwent heart transplantation and additional transcriptomic and proteomic analyses were conducted to identify differentially expressed genes (DEGs) and proteins (DEPs). Additionally, cardiac magnetic resonance imaging was utilized to evaluate myocardial fibrosis. Statistically significant disparities were observed between the two age groups with respect to clinical characteristics and clinical outcomes. Patients in the ≤3-year-old group exhibited a more favorable prognosis. Multi-omics integrative analysis revealed that genes associated with inflammatory responses and energy metabolism impairment—notably PDK4, CHI3L1, ZBP1 and ANXA1 —were enriched in the younger group. In contrast, myocardial inflammation and fibrosis were the predominant features in the older group, as evidenced by the significant upregulation of COL1α1, CTGF, RO60 and MAT2B . Conclusions: At both the transcriptomic and translational levels, we uncovered global variations in miRNAs and proteins associated with DCM, following stratification of patients by the 3-year age cutoff. Specifically, energy metabolism dysregulation plays a pivotal role in younger pediatric patients, whereas irreversible myocardial fibrosis may underlie the suboptimal response to conservative therapy in older pediatric patients.